Safety in Lactation: Corticosteroids

9 November 2020There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…

What steroid supplementation is required for a patient with primary adrenal insufficiency undergoing a dental procedure?

5 December 2019This Medicines Q&A gives guidance on dental procedures for which steroid supplementation may be required in patients with primary adrenal insufficiency and gives advice on…

If antidepressant-induced hyponatraemia has been diagnosed, how should the depression be treated?

10 June 2019This Medicines Q&A evaluates the evidence available on the management of depression in patients with antidepressant-induced hyponatraemia. Summary Most antidepressants are associated with hyponatraemia, with…
Search Articles

Medicine Compliance Aid Stability

FlorinefBristol-Myers Squibb Pharmaceutical Ltd

Bristol-Myers Squibb Pharmaceutical Ltd
Tablets 0.1mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from heat
Store in a refrigerator (2°-8°C). Keep the bottle tightly closed to protect from moisture. Protect from light. Hygroscopic. Due to the hygroscopic nature of the tablets, maximum 8 day expiry in a MCA.
12 February 2015

Lactation Safety Information

No published evidence of safety
Amount in milk unlikely to be clinically relevant
Used in full-term neonates from birth for adrenocortical insufficiency
29 July 2020